Thailand to legislate medical marijuana, signals no re-criminalising
Thailand among first in Asia to liberalise marijuana use
Regulations sketchy, despite business boom
Measures to curb recreational use unclear
Local industry tipped to top $1 billion by 2025
Adds comment from PM secretary-general in paragraphs 7-8, analyst in paragraphs 13-14
By Chayut Setboonsarng and Panarat Thepgumpanat
BANGKOK, July 23 (Reuters) -Thailand will work towards legislating marijuana for medical use, a deputy prime minister said Tuesday, signalling a U-turn on plans to re-criminalise the plant and another change in the government's hazy position on cannabis.
Thailand in 2022 became one of the first countries in Asia to decriminalise marijuana, doing so without a law to govern it or clear regulations in place to prevent its recreational usage.
The move, however, led to an explosion of recreational use and the launch of tens of thousands of cannabis cafes and retailers enabling it, prompting public concern about its abuse.
Deputy premier Anutin Charnvirakul, whose party was instrumental in pushing for marijuana liberalisation, said Prime Minister Srettha Thavisin had now agreed that legislation was the appropriate step to take.
"I thank the prime minister for considering this matter and deciding on issuing an act," Anutin said.
The government has maintained recreational use of cannabis was not allowed and Srettha, who belongs to a different party, had said he would re-criminalise it due to concerns over abuse, with an exception for medical use and research.
"It will be a matter of law and debated in parliament where there is already a draft law," secretary-general to the prime minister Prommin Lertsuridej told Reuters.
"Whether it is a narcotic or not is up to parliament."
A draft law on marijuana was submitted to the legislature under the previous administration but parliament was dissolved ahead of an election last year, without a vote taken.
It was not immediately clear whether steps would be taken to crack down on recreational cannabis use, as Srettha has advocated.
Thailand has seen rapid growth of a domestic retail sector for marijuana, an industry projected to be worth up to $1.2 billion by 2025.
Anutin's Bhumjaithai Party, the second biggest in the ruling coalition, has advocated for marijuana for health and economic purposes, but officially not for recreational use, and has argued against re-criminalising it.
Nattabhorn Buamahakul, Managing Partner at government affairs consultancy, Vero Advocacy, said the latest development indicated there was now better coordination between parties in government on the complex cannabis issue.
"The policy reversal reflects greater alignment between the coalition parties when compared to last year when the government was formed," Nattabhorn said.
Reporting by Chayut Setboonsarng and Panarat Thepgumpanat; Editing by Martin Petty
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
